Published in Gene Therapy Weekly, February 15th, 2001
Jon M. Wigginton of the U.S. National Cancer Institute was one of the study's leaders. He and fellow researchers announced that by using genetically transformed mice with mammary carcinoma, they were able to observe the cytokine combination deliver a powerful one-two punch to cancer cells.
Tumor neovascularization was one target of the novel therapy. "This regimen inhibits neovascularization of established...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.